Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats

Journal of Pineal Research

Volumn 59, Issue 1, 2015, Pages 70-79

  Agil, Ahmad ^a   El Hammadi, Mazen ^a,b   Jiménez Aranda, Aroa ^a   Tassi, Mohamed ^a   Abdo, Walied ^a,c   Fernández Vázquez, Gumersindo ^d   Reiter, Russel J ^e  

^a UNIVERSITY OF GRANADA   (Spain)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c Kafrelsheikh University   (Egypt)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

diabetes; liver; melatonin; mitochondria; obesity; ZDF rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; GLYCOGEN; MELATONIN; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING; CELL VACUOLE; CONTROLLED STUDY; DIABETIC OBESITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FATTY LIVER; HISTOPATHOLOGY; LIPID STORAGE; LIVER FUNCTION; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL DYSFUNCTION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; RESPIRATION CONTROL; RESPIRATORY CHAIN; ZUCKER DIABETIC FATTY RAT; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OBESITY; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER; MELATONIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OBESITY; RATS; RNA INTERFERENCE;

EID: 84934285544     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12241     Document Type: Article

References (70)

1. Smith RA, Hartley RC, Cocheme HM, et al., Mitochondrial pharmacology. Trends Pharmacol Sci 2012; 33: 341-352.
2. Mantena SK, King AL, Andringa KK, et al., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 2008; 44: 1259-1272.
3. Kim JA, Wei Y, Sowers JR,. Role of mitochondrial dysfunction in insulin resistance. Circ Res 2008; 102: 401-414.
4. Perez-Carreras M, Del Hoyo P, Martin MA, et al., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007.
5. Vial G, Dubouchaud H, Leverve XM,. Liver mitochondria and insulin resistance. Acta Biochim Pol 2010; 57: 389-392.
6. Dey A, Swaminathan K,. Hyperglycemia-induced mitochondrial alterations in liver. Life Sci 2010; 87: 197-214.
7. Zavodnik IB, Lapshina EA, Cheshchevik VT, et al., Melatonin and succinate reduce rat liver mitochondrial dysfunction in diabetes. J Physiol Pharmacol 2011; 62: 421-427.
8. Escames G, Acuña-Castroviejo D, Lõpez LC, et al., Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006; 58: 1153-1165.
9. Ganguly S, Coon SL, Klein DC,. Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation. Cell Tiss Res 2002; 309: 127-137.
10. Stehle JH, Saade A, Rawashdeh O, et al., A survey of molecular details in the human pineal in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
11. Venegas C, Garcia JA, Escames G, et al., Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-227.
12. Acuna-Castroviejo D, Escames G, Venegas C, et al., Extrapineal melatonin: sources, regulation and potential functions. Cell Mol Life Sci 2014; 71: 2997-3025.
13. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al., A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
14. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
15. Tan DX, Manchester L, Fuentes-Broto L, et al., Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obesity Rev 2011; 12: 167-188.
16. Satapati S, He T, Inagaki T, et al., Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 2008; 57: 2012-2021.
17. Absi E, Ayala A, Machado A, et al., Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. J Pineal Res 2000; 29: 40-47.
18. Hu SL, Yin S, Jiang XD, et al., Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol 2009; 616: 287-292.
19. Jiménez-Aranda A, Fernández-Vázquez G, Serrano MM, et al., Melatonin improves mitochondrial function in inguinal white adipose tissue of Zucker diabetic fatty rats. J Pineal Res 2014; 57: 103-109.
20. Sahna E, Parlakpinar H, Vardi N, et al., Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem 2004; 106: 331-336.
21. Martin M, Macias M, Escames G, et al., Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000; 28: 242-248.
22. González MA, Contini M, Millen N, et al., Role of melatonin in the oxidative damage prevention at different times of hepatic regeneration. Cell Biochem Funct 2012; 30: 701-708.
23. Bruck R, Aeed H, Avni Y, et al., Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J Hepatol 2004; 40: 86-93.
24. Cheshchevik VT, Dremza IK, Lapshina EA, et al., Corrections by melatonin of liver mitochondrial disorders under diabetes and acute intoxication in rats. Cell Biochem Funct 2011; 29: 481-488.
25. Guven A, Yavuz O, Cam M, et al., Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem 2006; 108: 85-93.
26. Kireev R, Samuel B, Sara C, et al., Melatonin administration prevents inflammation processes and reduces liver injury in Zucker rats after ischemia/reperfusion. J Hepatol 2011; 54: S210-S211.
27. Uchimura Y, Uchimura N, Kumashiro R, et al., Changes in melatonin concentrations during IFN therapy. J Hepatol 1999; 31: 1120-1130.
28. Leonard B, Watson R, Loomes K, et al., Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 2005; 42: 162-170.
29. Griffen SC, Wang J, German MS,. A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat. Diabetes 2001; 50: 63-68.
30. Agil A, Rosado I, Ruiz R, et al., Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res 2012; 52: 203-210.
31. Agil A, Reiter RJ, Jimenez-Aranda A, et al., Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. J Pineal Res 2013; 54: 381-388.
32. Agil A, Navarro-Alarcon M, Ruiz R, et al., Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res 2011; 50: 207-212.
33. Navarro-Alarcon M, Ruiz-Ojeda FJ, Blanca-Herrera RM, et al., Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats. Nutrition 2013; 29: 785-789.
34. Sutken E, Aral E, Ozdemir F, et al., Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney. Int J Toxicol 2007; 26: 81-87.
35. Brunt EMJC, Di Bisceglie AM, Neuschwander- Tetri BA, et al., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastro Enterol 1999; 94: 2467-2474.
36. Lopez-Navarro AT, Bueno JD, Gil A, et al., Morphological changes in hepatocytes of rats deprived of dietary nucleotides. Brit J Nutr 1996; 76: 579-589.
37. Gnaiger E, Kuznetsov AV, Schneeberger S, et al., Mitochondria in the cold. In: Life in the Cold, Heldmaier G, Klingenspor M, eds., Springer, New York, 2000; pp. 431-442.
38. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
39. Petrosillo G, Portincasa P, Grattagliano I, et al., Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochem Biophys Acta 2007; 1767: 1260-1267.
40. Gnaiger E, Mendez G, Hand SC,. High phosphorylation efficiency and depression of uncoupled respiration in mitochondria under hypoxia. Proc Natl Acad Sci USA 2000; 97: 11080-11085.
41. Lopez A, Garcia JA, Escames G, et al., Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009; 46: 188-198.
42. Barrientos A,. In vivo and in organelle assessment of OXPHOS activities. Methods 2002; 26: 307-316.
43. Ziegler DM, Doeg KA,. Studies on the electron transport system. XLIII. The isolation of a succinic-coenzyme Q reductase from beef heart mitochondria. Arch Biochem Biophys 1962; 97: 41-50.
44. Rieske JS,. Preparation and properties of reduced coenzyme Q-cytochrome c reductase (complex III of the respiratory chain). Meth Enzymol 1967; 10: 239-245.
45. Chida J, Yamane K, Takei T, et al., An efficient extraction method for quantitation of adenosine triphosphate in mammalian tissues and cells. Anal Chim Acta 2012; 727: 8-12.
46. Franko A, Von Kleist-Retzow J-C, Neschen S, et al., Liver adapts mitochondrial function to insulin resistant and diabetic states in mice. J Hepatol 2014; 60: 816-823.
47. Shimamura M, Nakagami H, Shimosato T, et al., Irbesartan improves endothelial dysfunction, abnormal lipid profile, proteinuria and liver dysfunction in Zucker diabetic fatty rats independent of glucose and insulin levels. Exp Ther Med 2011; 2: 957-961.
48. Hatzis G, Ziakas P, Kavantzas N, et al., Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol 2013; 5: 160.
49. Floettmann E, Gregory L, Teague J, et al., Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases. Toxicol Pathol 2010; 38: 393-401.
50. Jheng HF, Tsai PJ, Guo SM, et al., Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 2012; 32: 309-319.
51. Wei Y, Clark SE, Thyfault JP, et al., Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. Am J Pathol 2009; 174: 1329-1337.
52. Vickers AE,. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors. Toxicol Pathol 2009; 37: 78-88.
53. Fromenty B, Pessayre D,. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Therap 1995; 67: 101-154.
54. Pessayre D, Mansouri A, Haouzi D, et al., Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-373.
55. Chan K, Truong D, Shangari N, et al., Drug-induced mitochondrial toxicity. Exp Opin Drug Metab Toxicol 2005; 1: 655-669.
56. Schrauwen P,. Of the fit and the fat: mitochondrial abnormalities and type 2 diabetes mellitus. J Clin Endocrinol Metab 2007; 92: 1229-1231.
57. Blanchette-Mackie EJ, Scow RO,. Movement of lipolytic products to mitochondria in brown adipose tissue of young rats: an electron microscope study. J Lipid Res 1983; 24: 229-244.
58. Tarnopolsky MA, Rennie CD, Robertshaw HA, et al., Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1271-R1278.
59. Bosma M, Minnaard R, Sparks LM, et al., The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria. Histochem Cell Biol 2012; 137: 205-216.
60. Wardlaw GM, Kaplan ML,. Oxygen consumption and oxidative capacity of hepatocytes from young male obese and nonobese Zucker rats. Proc Soc Exp Biol Med 1986; 183: 199-206.
61. Teodoro J, Rolo AP, Oliveira PJ, et al., Decreased ANT content in Zucker fatty rats: relevance for altered hepatic mitochondrial bioenergetics in steatosis. FEBS Lett 2006; 580: 2153-2157.
62. Kucera O, Garnol T, Lotkova H, et al., The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. Physiol Res 2011; 60: 317-328.
63. Rolo AP, Palmeira CM,. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212: 167-178.
64. Sato N,. Central role of mitochondria in metabolic regulation of liver pathophysiology. J Gastroenterol Hepatol 2007; 22 (Suppl 1): S1-S6.
65. Mootha VK, Lindgren CM, Eriksson KF, et al., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
66. Cheng Z, Guo S, Copps K, et al., Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 2009; 15: 1307-1311.
67. Okatani Y, Wakatsuki A, Reiter RJ, et al., Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin. J Pineal Res 2002; 33: 127-133.
68. Reyes-Toso CF, Rebagliati IR, Ricci CR, et al., Effect of melatonin treatment on oxygen consumption by rat liver mitochondria. Amino Acids 2006; 31: 299-302.
69. Mawriz JH, Collado PS, Veneroso C, et al., A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
70. Jiménez-Aranda A, Fernández-Vázquez G, Campos D, et al., Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res 2013; 55: 416-423.